论文信息 - LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models - 字舞流文

LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models

T. Burke | R. Beckmann | M. Marshall | D. Barnard | G. Donoho | D. Barda | Gregory P Donoho | Constance King | Bonita D. Jones | H. Diaz | Gregory P. Donoho